title: Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
abstract: BACKGROUND
  The purpose of the present study was to assess the prognostic impact of positive surgical margins (R1) after liver resection (LR) of colorectal liver metastases (CRLM) in the era of modern chemotherapy regimens. R1 resection is a negative prognostic factor after LR of CRLM. The significance of R1 margins in the era of effective chemotherapy is unknown.
  
  
  METHODS
  From January 2000 to December 2009, 215 patients (177 men: 62 %; median age 60 years; range 30-84 years) underwent LR of CRLM. The LR was considered R1 (margin <1 mm) in 49 patients (23 %) and R0 in 166 patients (77 %). Overall, 108 (50 %) patients received preoperative chemotherapy and 156 (72 %) patients received postoperative chemotherapy.
  
  
  RESULTS
  With a median follow-up of 36 months (range 1-141 months), the 5-year overall survival (OS) rate (47 vs 40 %; p = 0.05) and the disease-free survival (DFS) rate (36 vs 23 %; p = 0.006) were significantly lower in the R1 group. Recurrence developed in 152 patients (71 %) and the rate of recurrence was significantly higher (84 vs 67 %; p = 0.02) in the R1 group. On multivariate analysis, N+ status of the colorectal primary tumor (p = 0.008), presence of radiologically occult disease (p = 0.04), and R1 resection (p = 0.03) were independent adverse predictors of OS. The N+ status of the primary tumor (p = 0.003) and R1 resection (p = 0.02) were independent adverse predictors of DFS. On multivariate analysis use of postoperative chemotherapy was the only independent predictor of improved DFS (p = 0.02) in the R1 group.
  
  
  CONCLUSIONS
  A positive resection margin remains a significant poor prognostic factor after LR of CRLM in the era of modern chemotherapy. Postoperative chemotherapy reduces recurrence rates after R1 resection of CRLM.
authors: Department of Digestive Surgery, Hôpital Saint Antoine, 184 Rue du Faubourg Saint Antoine, 75012, Paris, France.
authors: Hadrien
authors: H
authors: Tranchart
authors: Mircea
authors: M
authors: Chirica
authors: Matthieu
authors: M
authors: Faron
authors: Pierre
authors: P
authors: Balladur
authors: Leila Bengrine
authors: LB
authors: Lefevre
authors: Magali
authors: M
authors: Svrcek
authors: Aimery
authors: A
authors: de Gramont
authors: Emmanuel
authors: E
authors: Tiret
authors: François
authors: F
authors: Paye
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000473:pathology*; D003952:Diagnostic Imaging; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D008297:Male; D059146:Metastasectomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
references: Ann Surg. 2011 Aug;254(2):234-42
references: 21694583
references: Ann Surg. 2004 Dec;240(6):1052-61; discussion 1061-4
references: 15570210
references: J Clin Oncol. 2000 Aug;18(16):2938-47
references: 10944126
references: Lancet. 2008 Mar 22;371(9617):1007-16
references: 18358928
references: Ann Surg. 2012 Feb;255(2):237-47
references: 22041509
references: World J Surg. 1995 Jan-Feb;19(1):59-71
references: 7740812
references: Ann Surg. 2000 Apr;231(4):487-99
references: 10749608
references: J Surg Oncol. 1998 Oct;69(2):88-93
references: 9808511
references: Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8
references: 15383792
references: Ann Surg. 2004 Dec;240(6):1027-34; discussion 1035-6
references: 15570208
references: Br J Surg. 1997 Jul;84(7):977-80
references: 9240140
references: Cancer. 1996 Apr 1;77(7):1254-62
references: 8608500
references: Ann Surg Oncol. 2009 Sep;16(9):2395-410
references: 19506963
references: J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
references: 10655437
references: Arch Surg. 1992 May;127(5):561-8; discussion 568-9
references: 1575626
references: Eur J Surg Oncol. 2006 Jun;32(5):557-63
references: 16580811
references: J Clin Oncol. 2006 Jan 20;24(3):394-400
references: 16421419
references: Br J Surg. 2011 Oct;98(10):1463-75
references: 21710481
references: J Clin Oncol. 2005 Jan 20;23(3):502-9
references: 15659495
references: J Am Coll Surg. 2007 May;204(5):753-61; discussion 761-3
references: 17481478
references: Ann Surg. 2008 Oct;248(4):626-37
references: 18936576
references: Arch Surg. 2002 Jul;137(7):833-40
references: 12093342
references: Ann Surg. 2005 May;241(5):715-22, discussion 722-4
references: 15849507
references: J Clin Oncol. 2009 Dec 1;27(34):5727-33
references: 19786657
references: Br J Surg. 1997 Aug;84(8):1136-40
references: 9278662
references: Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
references: 10493478
references: J Clin Oncol. 1999 Nov;17(11):3560-8
references: 10550155
references: J Clin Oncol. 2006 Nov 1;24(31):4976-82
references: 17075115
references: Ann Surg. 2010 Nov;252(5):774-87
references: 21037433
references: Ann Surg. 2004 Aug;240(2):205-13
references: 15273542